More News
-
Tuesday | Dec 16, 2025
New treatments, and first of kind self-test for gonorrhoea
THE US Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin) and Innoviva’s Nuzolvence (zoliflodacin) for the treatment of uncomplicated urogenital gonorrhoea in adults and adolescents, the first drugs from new antibiotic classes to be approved for the disease in over three decades.
-
Tuesday | Dec 16, 2025
Kids’ homeopathy safety recall
KEY Sun Laboratories is recalling one batch of Key Sun Kids Travel Sickness Homeopathic Product, due to the risk of a small metal wire being present in the lozenge.
-
Tuesday | Dec 16, 2025
Bone meds may help chronic pain
BISPHOSPHONATES – medicines usually used to treat osteoporosis – may provide short-term pain relief for complex regional pain syndrome (CRPS), according to a research analysis published in the Annals of Internal Medicine today.
Subscribe to Pharmacy Daily now!
FREE Pharmacy Daily subscription - never miss another story!
